Please use this identifier to cite or link to this item:
http://hdl.handle.net/10637/15069
Ex vivo rabbit cornea diffusion studies with a soluble insert of moxifloxacin
See/Open:
Ex_Sebastian_DDTR_2018.JPG
69,96 kB
JPEG
See/Open:
Ex_Sebastian_DDTR_2018.pdf
Restricted Access
1,11 MB
Adobe PDF
Request a copy
Title: | Ex vivo rabbit cornea diffusion studies with a soluble insert of moxifloxacin |
Authors : | Sebastián Morelló, María Calatayud Pascual, María Aracely Rodilla Alama, Vicente Balaguer Fernández, Cristina López Castellano, Alicia Cristina |
Keywords: | Oftalmología; Ophthalmology; Drugs; Medicamento; Bacteria; Tratamiento médico; Medical treatment |
Publisher: | Springer Nature Controlled Release Society |
Citation: | Sebastián-Morelló, M., Calatayud-Pascual, M.A., Rodilla, V., Balaguer-Fernández, C. & López-Castellano, A. (2018). Ex vivo rabbit cornea diffusion studies with a soluble insert of moxifloxacin. Drug Delivery and Translational Research, vol. 8, i. 1, pp. 132–139. DOI: https://doi.org/10.1007/s13346-017-0443-y |
Abstract: | The objective of this research was to develop and evaluate an ocular insert for the controlled drug delivery of moxifloxacin which could perhaps be used in the treatment of corneal keratitis or even bacterial endophthalmitis. We have evaluated the ex vivo ocular diffusion of moxifloxacin through rabbit cornea, both fresh and preserved under different conditions. Histological studies were also carried out. Subsequently, drug matrix inserts were prepared using bioadhesive polymers. The inserts were evaluated for their physicochemical parameters. Ophthalmic ex vivo permeation of moxifloxacin was carried out with the most promising insert. The formulate insert was thin and provided higher ocular diffusion than commercial formulations. Ocular diffusion studies revealed significant differences between fresh and frozen corneas. Histological examinations also showed differences in the thickness of stroma between fresh and frozen corneas. The ophthalmic insert we have developed allows a larger quantity of moxifloxacin to permeate through the cornea than existing commercial formulations of the drug. Ocular delivery of moxifloxacin with this insert could be a new approach for the treatment of eye diseases. |
Description: | Este recurso no está disponible en acceso abierto por política de la editorial. |
URI: | http://hdl.handle.net/10637/15069 |
Rights : | http://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
ISSN: | 2190-393X 2190-3948 (Electrónico) |
Issue Date: | 2018 |
Center : | Universidad Cardenal Herrera-CEU |
Appears in Collections: | Dpto. Farmacia |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.